电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Chymotrypsin 抗体

This 小鼠 单克隆 antibody specifically detects Chymotrypsin in WB, ELISA, IF, IHC (fro) 和 IHC (p). It exhibits reactivity toward 人, 小鼠 和 大鼠. It has been mentioned in 2+ publications
产品编号 ABIN2472991
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Chymotrypsin 抗体 (ABIN2472991)

抗原

See all Chymotrypsin (CTRL) 抗体
Chymotrypsin (CTRL)

适用

  • 31
  • 8
  • 8
  • 3
  • 2
  • 1
  • 1
人, 小鼠, 大鼠

宿主

  • 27
  • 7
小鼠

克隆类型

  • 27
  • 7
单克隆

标记

  • 24
  • 3
  • 3
  • 2
  • 1
  • 1
This Chymotrypsin antibody is un-conjugated

应用范围

  • 28
  • 21
  • 10
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

克隆位点

4E1
  • 交叉反应

    小鼠, 大鼠

    产品特性

    Purified IgG

    纯化方法

    Purified

    免疫原

    Purified human pancreatic chymotrypsin

    亚型

    IgG3
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1.0 mg/mL
  • Larina, Bhat, Pickett, Launikonis, Shah, Kruger, Edwardson, Thorn: "Dynamic regulation of the large exocytotic fusion pore in pancreatic acinar cells." in: Molecular biology of the cell, Vol. 18, Issue 9, pp. 3502-11, (2007) (PubMed).

    Bockman, Guo, Büchler, Müller, Bergmann, Friess: "Origin and development of the precursor lesions in experimental pancreatic cancer in rats." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 83, Issue 6, pp. 853-9, (2003) (PubMed).

  • 抗原

    Chymotrypsin (CTRL)

    别名

    CHYMOTRYPSIN

    物质类

    Chemical

    基因ID

    11330

    UniProt

    Q99895
You are here: